Skip to main content
Premium Trial:

Request an Annual Quote

MDxHealth Signs on PPO Stratose

NEW YORK (GenomeWeb News) – MDxHealth today announced an agreement with preferred provider organization Stratose that gives its 12.4 million members access to the ConfirmMDx prostate cancer test.

Formerly operating as Coalition America, NPPN, OPPN, PlanCare America, 4MOST Health, Qualident and KeyClaims, Stratose has 850,000 direct and affiliate medical, dental, and workers' compensation provider contracts, MDxHealth said.

Jan Groen, CEO of MDxHealth, said that Stratose's network supplements more than 90 different third-party insurance payers. "With the addition of Stratose to our existing payer agreements, more than 80 million covered lives now have access to ConfirmMDx for prostate cancer," he said in a statement.

Today's announcement is the third deal MDxHealth has inked with a payor. In late July it said it signed agreements with healthcare cost management firm MultiPlan and PPO Three Rivers Provider Network to provide access to ConfirmMDx.

In late August, the Belgian firm said that revenues through the first half of 2013 had doubled year over year.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.